nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP1A2—chronic obstructive pulmonary disease	0.436	1	CbGaD
Bromazepam—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0665	0.199	CbGbCtD
Bromazepam—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.049	0.147	CbGbCtD
Bromazepam—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.049	0.147	CbGbCtD
Bromazepam—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0385	0.115	CbGbCtD
Bromazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0313	0.0935	CbGbCtD
Bromazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0211	0.0631	CbGbCtD
Bromazepam—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0206	0.0615	CbGbCtD
Bromazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0201	0.0602	CbGbCtD
Bromazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.018	0.0537	CbGbCtD
Bromazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0105	0.0315	CbGbCtD
Bromazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00995	0.0297	CbGbCtD
Bromazepam—Aggression—Montelukast—chronic obstructive pulmonary disease	0.0017	0.0113	CcSEcCtD
Bromazepam—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.0109	CcSEcCtD
Bromazepam—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00983	CcSEcCtD
Bromazepam—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00928	CcSEcCtD
Bromazepam—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00921	CcSEcCtD
Bromazepam—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.0092	CcSEcCtD
Bromazepam—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00876	CcSEcCtD
Bromazepam—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.0087	CcSEcCtD
Bromazepam—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00854	CcSEcCtD
Bromazepam—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00847	CcSEcCtD
Bromazepam—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00847	CcSEcCtD
Bromazepam—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00845	CcSEcCtD
Bromazepam—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00837	CcSEcCtD
Bromazepam—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.00126	0.0083	CcSEcCtD
Bromazepam—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.0082	CcSEcCtD
Bromazepam—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00815	CcSEcCtD
Bromazepam—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00769	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.00736	CcSEcCtD
Bromazepam—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00697	CcSEcCtD
Bromazepam—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.0069	CcSEcCtD
Bromazepam—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00686	CcSEcCtD
Bromazepam—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00684	CcSEcCtD
Bromazepam—Fracture—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00684	CcSEcCtD
Bromazepam—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00661	CcSEcCtD
Bromazepam—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.000985	0.00651	CcSEcCtD
Bromazepam—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000946	0.00625	CcSEcCtD
Bromazepam—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000935	0.00618	CcSEcCtD
Bromazepam—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.00618	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000928	0.00613	CcSEcCtD
Bromazepam—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000926	0.00612	CcSEcCtD
Bromazepam—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000889	0.00588	CcSEcCtD
Bromazepam—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000885	0.00585	CcSEcCtD
Bromazepam—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000861	0.0057	CcSEcCtD
Bromazepam—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000853	0.00564	CcSEcCtD
Bromazepam—Delusion—Prednisone—chronic obstructive pulmonary disease	0.00085	0.00562	CcSEcCtD
Bromazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000837	0.00554	CcSEcCtD
Bromazepam—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000833	0.00551	CcSEcCtD
Bromazepam—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000828	0.00547	CcSEcCtD
Bromazepam—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000822	0.00544	CcSEcCtD
Bromazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.00534	CcSEcCtD
Bromazepam—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000807	0.00533	CcSEcCtD
Bromazepam—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000792	0.00523	CcSEcCtD
Bromazepam—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00078	0.00516	CcSEcCtD
Bromazepam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000776	0.00513	CcSEcCtD
Bromazepam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000771	0.0051	CcSEcCtD
Bromazepam—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000761	0.00503	CcSEcCtD
Bromazepam—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000754	0.00499	CcSEcCtD
Bromazepam—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000754	0.00499	CcSEcCtD
Bromazepam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000748	0.00495	CcSEcCtD
Bromazepam—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00488	CcSEcCtD
Bromazepam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000732	0.00484	CcSEcCtD
Bromazepam—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000716	0.00474	CcSEcCtD
Bromazepam—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000712	0.00471	CcSEcCtD
Bromazepam—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000712	0.00471	CcSEcCtD
Bromazepam—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00471	CcSEcCtD
Bromazepam—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000711	0.0047	CcSEcCtD
Bromazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00071	0.0047	CcSEcCtD
Bromazepam—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000703	0.00465	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.0007	0.00463	CcSEcCtD
Bromazepam—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000699	0.00462	CcSEcCtD
Bromazepam—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000698	0.00461	CcSEcCtD
Bromazepam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000689	0.00456	CcSEcCtD
Bromazepam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000683	0.00452	CcSEcCtD
Bromazepam—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000683	0.00452	CcSEcCtD
Bromazepam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000677	0.00448	CcSEcCtD
Bromazepam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000677	0.00447	CcSEcCtD
Bromazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000673	0.00445	CcSEcCtD
Bromazepam—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000673	0.00445	CcSEcCtD
Bromazepam—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000672	0.00445	CcSEcCtD
Bromazepam—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000672	0.00445	CcSEcCtD
Bromazepam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000669	0.00443	CcSEcCtD
Bromazepam—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000668	0.00442	CcSEcCtD
Bromazepam—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000668	0.00442	CcSEcCtD
Bromazepam—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00438	CcSEcCtD
Bromazepam—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000659	0.00436	CcSEcCtD
Bromazepam—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000659	0.00435	CcSEcCtD
Bromazepam—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000656	0.00434	CcSEcCtD
Bromazepam—Tension—Formoterol—chronic obstructive pulmonary disease	0.000656	0.00433	CcSEcCtD
Bromazepam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000656	0.00433	CcSEcCtD
Bromazepam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00429	CcSEcCtD
Bromazepam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00429	CcSEcCtD
Bromazepam—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000642	0.00425	CcSEcCtD
Bromazepam—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000642	0.00425	CcSEcCtD
Bromazepam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000638	0.00422	CcSEcCtD
Bromazepam—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.0042	CcSEcCtD
Bromazepam—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00417	CcSEcCtD
Bromazepam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000631	0.00417	CcSEcCtD
Bromazepam—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000629	0.00416	CcSEcCtD
Bromazepam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00414	CcSEcCtD
Bromazepam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00414	CcSEcCtD
Bromazepam—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000623	0.00412	CcSEcCtD
Bromazepam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00409	CcSEcCtD
Bromazepam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00406	CcSEcCtD
Bromazepam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00406	CcSEcCtD
Bromazepam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000613	0.00405	CcSEcCtD
Bromazepam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00405	CcSEcCtD
Bromazepam—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.00401	CcSEcCtD
Bromazepam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000601	0.00398	CcSEcCtD
Bromazepam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000595	0.00393	CcSEcCtD
Bromazepam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00391	CcSEcCtD
Bromazepam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.0039	CcSEcCtD
Bromazepam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00059	0.0039	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000583	0.00386	CcSEcCtD
Bromazepam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00383	CcSEcCtD
Bromazepam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00382	CcSEcCtD
Bromazepam—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000571	0.00378	CcSEcCtD
Bromazepam—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000567	0.00375	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.00373	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000565	0.00373	CcSEcCtD
Bromazepam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00369	CcSEcCtD
Bromazepam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00368	CcSEcCtD
Bromazepam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00368	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000553	0.00366	CcSEcCtD
Bromazepam—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00361	CcSEcCtD
Bromazepam—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00361	CcSEcCtD
Bromazepam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00354	CcSEcCtD
Bromazepam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00354	CcSEcCtD
Bromazepam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000534	0.00353	CcSEcCtD
Bromazepam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00352	CcSEcCtD
Bromazepam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00352	CcSEcCtD
Bromazepam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.0035	CcSEcCtD
Bromazepam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00053	0.0035	CcSEcCtD
Bromazepam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.0035	CcSEcCtD
Bromazepam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00349	CcSEcCtD
Bromazepam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00347	CcSEcCtD
Bromazepam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00346	CcSEcCtD
Bromazepam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000519	0.00343	CcSEcCtD
Bromazepam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000517	0.00342	CcSEcCtD
Bromazepam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.0034	CcSEcCtD
Bromazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00337	CcSEcCtD
Bromazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00337	CcSEcCtD
Bromazepam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.00335	CcSEcCtD
Bromazepam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00334	CcSEcCtD
Bromazepam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00332	CcSEcCtD
Bromazepam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00331	CcSEcCtD
Bromazepam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00329	CcSEcCtD
Bromazepam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00324	CcSEcCtD
Bromazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00321	CcSEcCtD
Bromazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00321	CcSEcCtD
Bromazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00318	CcSEcCtD
Bromazepam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00317	CcSEcCtD
Bromazepam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00317	CcSEcCtD
Bromazepam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.00316	CcSEcCtD
Bromazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00314	CcSEcCtD
Bromazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00313	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00311	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00311	CcSEcCtD
Bromazepam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00311	CcSEcCtD
Bromazepam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00311	CcSEcCtD
Bromazepam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00311	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00305	CcSEcCtD
Bromazepam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00304	CcSEcCtD
Bromazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00303	CcSEcCtD
Bromazepam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000456	0.00301	CcSEcCtD
Bromazepam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.003	CcSEcCtD
Bromazepam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00299	CcSEcCtD
Bromazepam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00298	CcSEcCtD
Bromazepam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00297	CcSEcCtD
Bromazepam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00297	CcSEcCtD
Bromazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000449	0.00297	CcSEcCtD
Bromazepam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00296	CcSEcCtD
Bromazepam—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00296	CcSEcCtD
Bromazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00295	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00294	CcSEcCtD
Bromazepam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00293	CcSEcCtD
Bromazepam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00284	CcSEcCtD
Bromazepam—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000426	0.00282	CcSEcCtD
Bromazepam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00282	CcSEcCtD
Bromazepam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00281	CcSEcCtD
Bromazepam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000426	0.00281	CcSEcCtD
Bromazepam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00281	CcSEcCtD
Bromazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.0028	CcSEcCtD
Bromazepam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00276	CcSEcCtD
Bromazepam—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000415	0.00274	CcSEcCtD
Bromazepam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00266	CcSEcCtD
Bromazepam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00266	CcSEcCtD
Bromazepam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000401	0.00265	CcSEcCtD
Bromazepam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000393	0.0026	CcSEcCtD
Bromazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.00259	CcSEcCtD
Bromazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000391	0.00259	CcSEcCtD
Bromazepam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00255	CcSEcCtD
Bromazepam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00255	CcSEcCtD
Bromazepam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00255	CcSEcCtD
Bromazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000383	0.00253	CcSEcCtD
Bromazepam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00251	CcSEcCtD
Bromazepam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000378	0.0025	CcSEcCtD
Bromazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00244	CcSEcCtD
Bromazepam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00241	CcSEcCtD
Bromazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00238	CcSEcCtD
Bromazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00238	CcSEcCtD
Bromazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00234	CcSEcCtD
Bromazepam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00229	CcSEcCtD
Bromazepam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00229	CcSEcCtD
Bromazepam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00227	CcSEcCtD
Bromazepam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00227	CcSEcCtD
Bromazepam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00227	CcSEcCtD
Bromazepam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00227	CcSEcCtD
Bromazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00226	CcSEcCtD
Bromazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00226	CcSEcCtD
Bromazepam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.00225	CcSEcCtD
Bromazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00225	CcSEcCtD
Bromazepam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00225	CcSEcCtD
Bromazepam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00223	CcSEcCtD
Bromazepam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00222	CcSEcCtD
Bromazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00221	CcSEcCtD
Bromazepam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00216	CcSEcCtD
Bromazepam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00215	CcSEcCtD
Bromazepam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00214	CcSEcCtD
Bromazepam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00214	CcSEcCtD
Bromazepam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00214	CcSEcCtD
Bromazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00213	CcSEcCtD
Bromazepam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000317	0.0021	CcSEcCtD
Bromazepam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.00207	CcSEcCtD
Bromazepam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00202	CcSEcCtD
Bromazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00199	CcSEcCtD
Bromazepam—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000297	0.00196	CcSEcCtD
Bromazepam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00195	CcSEcCtD
Bromazepam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00191	CcSEcCtD
Bromazepam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00187	CcSEcCtD
Bromazepam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00175	CcSEcCtD
Bromazepam—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00174	CcSEcCtD
Bromazepam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00164	CcSEcCtD
Bromazepam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00161	CcSEcCtD
Bromazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000242	0.0016	CcSEcCtD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000233	0.003	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000232	0.00298	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000231	0.00297	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000229	0.00294	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000229	0.00294	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000229	0.00294	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000229	0.00294	CbGpPWpGaD
Bromazepam—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00151	CcSEcCtD
Bromazepam—GABRB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000227	0.00292	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000226	0.0029	CbGpPWpGaD
Bromazepam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.0029	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000225	0.00289	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000224	0.00287	CbGpPWpGaD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00147	CcSEcCtD
Bromazepam—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000222	0.00285	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00022	0.00282	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00022	0.00282	CbGpPWpGaD
Bromazepam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00144	CcSEcCtD
Bromazepam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00278	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000215	0.00276	CbGpPWpGaD
Bromazepam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00142	CcSEcCtD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000214	0.00275	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000212	0.00273	CbGpPWpGaD
Bromazepam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Bromazepam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00138	CcSEcCtD
Bromazepam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00138	CcSEcCtD
Bromazepam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00268	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000208	0.00267	CbGpPWpGaD
Bromazepam—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000207	0.00266	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000207	0.00266	CbGpPWpGaD
Bromazepam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00135	CcSEcCtD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000204	0.00262	CbGpPWpGaD
Bromazepam—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00262	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000203	0.0026	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000201	0.00258	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000201	0.00258	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000199	0.00256	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000198	0.00255	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000197	0.00253	CbGpPWpGaD
Bromazepam—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00252	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000196	0.00251	CbGpPWpGaD
Bromazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00129	CcSEcCtD
Bromazepam—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.0025	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000194	0.0025	CbGpPWpGaD
Bromazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00249	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000194	0.00249	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000193	0.00247	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000192	0.00246	CbGpPWpGaD
Bromazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.00246	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000189	0.00243	CbGpPWpGaD
Bromazepam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00125	CcSEcCtD
Bromazepam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000189	0.00242	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000188	0.00242	CbGpPWpGaD
Bromazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00242	CbGpPWpGaD
Bromazepam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00123	CcSEcCtD
Bromazepam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Bromazepam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Bromazepam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000185	0.00238	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000185	0.00238	CbGpPWpGaD
Bromazepam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00122	CcSEcCtD
Bromazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.00122	CcSEcCtD
Bromazepam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000182	0.00234	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000181	0.00232	CbGpPWpGaD
Bromazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000181	0.00232	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000178	0.00228	CbGpPWpGaD
Bromazepam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00117	CcSEcCtD
Bromazepam—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000175	0.00225	CbGpPWpGaD
Bromazepam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00116	CcSEcCtD
Bromazepam—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00224	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000173	0.00222	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00222	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000171	0.0022	CbGpPWpGaD
Bromazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.0022	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000171	0.0022	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000166	0.00213	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000165	0.00212	CbGpPWpGaD
Bromazepam—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000162	0.00208	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000158	0.00203	CbGpPWpGaD
Bromazepam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Bromazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00202	CbGpPWpGaD
Bromazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00202	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000155	0.002	CbGpPWpGaD
Bromazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00102	CcSEcCtD
Bromazepam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000154	0.00198	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000153	0.00196	CbGpPWpGaD
Bromazepam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000152	0.001	CcSEcCtD
Bromazepam—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00195	CbGpPWpGaD
Bromazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00194	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000151	0.00194	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00015	0.00192	CbGpPWpGaD
Bromazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.00192	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000149	0.00191	CbGpPWpGaD
Bromazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.0019	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000148	0.0019	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000145	0.00186	CbGpPWpGaD
Bromazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000938	CcSEcCtD
Bromazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00182	CbGpPWpGaD
Bromazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00181	CbGpPWpGaD
Bromazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00179	CbGpPWpGaD
Bromazepam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000902	CcSEcCtD
Bromazepam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000895	CcSEcCtD
Bromazepam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000894	CcSEcCtD
Bromazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000889	CcSEcCtD
Bromazepam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000843	CcSEcCtD
Bromazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000127	0.00163	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00162	CbGpPWpGaD
Bromazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00156	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000119	0.00153	CbGpPWpGaD
Bromazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00147	CbGpPWpGaD
Bromazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00143	CbGpPWpGaD
Bromazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.0014	CbGpPWpGaD
Bromazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00138	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00135	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00135	CbGpPWpGaD
Bromazepam—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00135	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000104	0.00133	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000103	0.00133	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000102	0.00131	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0001	0.00129	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.93e-05	0.00128	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.8e-05	0.00126	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.2e-05	0.00118	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	9.19e-05	0.00118	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.99e-05	0.00116	CbGpPWpGaD
Bromazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.88e-05	0.00114	CbGpPWpGaD
Bromazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.81e-05	0.00113	CbGpPWpGaD
Bromazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.47e-05	0.00109	CbGpPWpGaD
Bromazepam—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.00107	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.35e-05	0.00107	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.23e-05	0.00106	CbGpPWpGaD
Bromazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.08e-05	0.00104	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.75e-05	0.000995	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.66e-05	0.000984	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.29e-05	0.000937	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.16e-05	0.000919	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.12e-05	0.000915	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.96e-05	0.000894	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.87e-05	0.000882	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.86e-05	0.000882	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.79e-05	0.000873	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.79e-05	0.000873	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.58e-05	0.000845	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.54e-05	0.000839	CbGpPWpGaD
Bromazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.45e-05	0.000828	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.44e-05	0.000827	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.4e-05	0.000822	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.35e-05	0.000816	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.31e-05	0.000811	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.07e-05	0.000779	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.04e-05	0.000776	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.98e-05	0.000768	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.97e-05	0.000767	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.79e-05	0.000744	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.68e-05	0.000729	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.59e-05	0.000719	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.51e-05	0.000708	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.45e-05	0.0007	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.45e-05	0.0007	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.37e-05	0.00069	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.3e-05	0.000681	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.00068	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.21e-05	0.00067	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.15e-05	0.000661	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.94e-05	0.000634	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.91e-05	0.00063	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.88e-05	0.000627	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.87e-05	0.000625	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.71e-05	0.000605	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000601	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.66e-05	0.000599	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.000593	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.61e-05	0.000592	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.61e-05	0.000592	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.57e-05	0.000588	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.5e-05	0.000578	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.49e-05	0.000577	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.42e-05	0.000567	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.42e-05	0.000567	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.41e-05	0.000567	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.39e-05	0.000563	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.31e-05	0.000553	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.28e-05	0.000549	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.24e-05	0.000545	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.2e-05	0.00054	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.2e-05	0.00054	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.19e-05	0.000538	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.13e-05	0.00053	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.08e-05	0.000524	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.08e-05	0.000524	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.95e-05	0.000508	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.87e-05	0.000497	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.85e-05	0.000494	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.82e-05	0.000491	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.79e-05	0.000487	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.000484	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.76e-05	0.000484	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.65e-05	0.000468	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.6e-05	0.000462	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.36e-05	0.000431	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.31e-05	0.000425	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.23e-05	0.000415	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.23e-05	0.000415	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.19e-05	0.00041	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.19e-05	0.000409	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	3.14e-05	0.000404	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.13e-05	0.000402	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.09e-05	0.000397	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.97e-05	0.000381	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.93e-05	0.000377	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.93e-05	0.000376	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.92e-05	0.000375	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.83e-05	0.000363	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000361	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.78e-05	0.000356	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000353	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.7e-05	0.000346	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.68e-05	0.000345	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.65e-05	0.00034	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.63e-05	0.000338	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.59e-05	0.000332	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.49e-05	0.00032	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.47e-05	0.000318	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000312	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.26e-05	0.000291	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.26e-05	0.00029	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.00029	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000269	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.94e-05	0.00025	CbGpPWpGaD
Bromazepam—Clonazepam—ALB—chronic obstructive pulmonary disease	1.92e-05	0.417	CrCbGaD
Bromazepam—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000243	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000226	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000221	CbGpPWpGaD
Bromazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.37	CrCbGaD
Bromazepam—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000218	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000199	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.5e-05	0.000193	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.46e-05	0.000187	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000183	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.36e-05	0.000174	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.00017	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000157	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000154	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000153	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000151	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.09e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000131	CbGpPWpGaD
Bromazepam—Diazepam—ALB—chronic obstructive pulmonary disease	9.85e-06	0.213	CrCbGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.52e-06	0.000122	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.32e-06	0.00012	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.19e-06	0.000118	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.06e-06	0.000116	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.44e-06	0.000108	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8e-06	0.000103	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.97e-06	0.000102	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.88e-06	0.000101	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.19e-06	9.23e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.16e-06	9.19e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.06e-06	9.07e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	7.05e-06	9.06e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.75e-06	8.66e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.62e-06	8.51e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.58e-06	8.45e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.24e-06	8.01e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.52e-06	7.1e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.45e-06	7e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.44e-06	6.99e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.2e-06	6.68e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.08e-06	6.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.81e-06	6.18e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.24e-06	5.44e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.05e-06	5.21e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.27e-06	4.2e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.13e-06	4.02e-05	CbGpPWpGaD
